Log in

Navidea Biopharmaceuticals News Headlines (NYSEAMERICAN:NAVB)

$1.18
+0.20 (+20.41 %)
(As of 02/16/2020 04:00 PM ET)
Today's Range
$1.08
Now: $1.18
$1.30
50-Day Range N/A
52-Week Range
$0.49
Now: $1.18
$4.20
Volume768,874 shs
Average Volume156,699 shs
Market Capitalization$21.33 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Navidea Biopharmaceuticals (NYSEAMERICAN NAVB) News Headlines

Source:
DateHeadline
Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) Short Interest Down 7.0% in JanuaryNavidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) Short Interest Down 7.0% in January
www.americanbankingnews.com - February 15 at 5:26 AM
Navidea up 13% premarket on $7.6M capital raiseNavidea up 13% premarket on $7.6M capital raise
seekingalpha.com - February 14 at 10:13 AM
The  of Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB), John Scott, Just Bought 11% More SharesThe of Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB), John Scott, Just Bought 11% More Shares
finance.yahoo.com - December 14 at 1:52 PM
What Kind Of Shareholders Own Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)?What Kind Of Shareholders Own Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)?
finance.yahoo.com - November 13 at 12:43 PM
Edited Transcript of NAVB earnings conference call or presentation 7-Nov-19 10:00pm GMTEdited Transcript of NAVB earnings conference call or presentation 7-Nov-19 10:00pm GMT
finance.yahoo.com - November 8 at 6:56 PM
Navidea Biopharmaceuticals Reports Third Quarter 2019 Financial ResultsNavidea Biopharmaceuticals Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 7 at 4:12 PM
Navidea Biopharmaceuticals to Host Third Quarter 2019 Earnings Conference Call and Corporate UpdateNavidea Biopharmaceuticals to Host Third Quarter 2019 Earnings Conference Call and Corporate Update
finance.yahoo.com - October 31 at 8:20 AM
BRIEF-Navidea Biopharmaceuticals Announces Positive Results Of First Interim Analysis Of Ongoing Phase 2B Study In Rheumatoid ArthritisBRIEF-Navidea Biopharmaceuticals Announces Positive Results Of First Interim Analysis Of Ongoing Phase 2B Study In Rheumatoid Arthritis
www.msn.com - October 29 at 11:36 PM
Navidea Biopharmaceuticals Announces Positive Results of First Interim Analysis of Ongoing Phase 2B Study in Rheumatoid ArthritisNavidea Biopharmaceuticals Announces Positive Results of First Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis
finance.yahoo.com - October 29 at 8:32 AM
Navidea Biopharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceNavidea Biopharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 7 at 11:39 AM
Navidea Biopharmaceuticals Announces Receipt of Notice of AwardNavidea Biopharmaceuticals Announces Receipt of Notice of Award
finance.yahoo.com - August 27 at 11:37 AM
Edited Transcript of NAVB earnings conference call or presentation 8-Aug-19 9:00pm GMTEdited Transcript of NAVB earnings conference call or presentation 8-Aug-19 9:00pm GMT
finance.yahoo.com - August 9 at 10:22 AM
Navidea Biopharmaceuticals Reports Second Quarter 2019 Financial ResultsNavidea Biopharmaceuticals Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 8 at 5:06 PM
Navidea Biopharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business UpdateNavidea Biopharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update
finance.yahoo.com - August 1 at 4:40 PM
What Caused The Opening Gap In Navidea Biopharmaceuticals?What Caused The Opening Gap In Navidea Biopharmaceuticals?
www.benzinga.com - July 11 at 4:42 PM
Navidea Biopharmaceuticals Announces SNMMI Press Release and Recognition of Phase 1/2 Study ResultsNavidea Biopharmaceuticals Announces SNMMI Press Release and Recognition of Phase 1/2 Study Results
finance.yahoo.com - June 24 at 6:51 PM
Navidea Biopharmaceuticals Announces Closing of Public Offering of Common StockNavidea Biopharmaceuticals Announces Closing of Public Offering of Common Stock
finance.yahoo.com - June 18 at 7:55 PM
Navidea Biopharmaceuticals prices stock offeringNavidea Biopharmaceuticals prices stock offering
seekingalpha.com - June 14 at 1:10 PM
Navidea up 128% after hours on regain of Manocept IPNavidea up 128% after hours on regain of Manocept IP
seekingalpha.com - June 14 at 1:10 PM
Navidea Biopharmaceuticals Regains Direct Control of Intellectual PropertyNavidea Biopharmaceuticals Regains Direct Control of Intellectual Property
finance.yahoo.com - June 13 at 4:36 PM
Edited Transcript of NAVB earnings conference call or presentation 8-May-19 9:00pm GMTEdited Transcript of NAVB earnings conference call or presentation 8-May-19 9:00pm GMT
finance.yahoo.com - May 9 at 11:25 AM
Navidea Biopharmaceuticals Reports First Quarter 2019 Financial ResultsNavidea Biopharmaceuticals Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 8 at 4:25 PM
Navidea Biopharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business UpdateNavidea Biopharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update
finance.yahoo.com - May 2 at 11:40 AM
Navidea Biopharmaceuticals Inc.Navidea Biopharmaceuticals Inc.
www.barrons.com - April 26 at 10:59 AM
Board approves reverse stock split for struggling Dublin-based public companyBoard approves reverse stock split for struggling Dublin-based public company
www.bizjournals.com - April 23 at 11:02 AM
Navidea Bio to reverse split shares 1:20Navidea Bio to reverse split shares 1:20
seekingalpha.com - April 22 at 10:41 AM
Mid-Afternoon Market Update: Arts-Way Manufacturing Drops After Q1 Results; Navidea Biopharmaceuticals Shares ClimbMid-Afternoon Market Update: Art's-Way Manufacturing Drops After Q1 Results; Navidea Biopharmaceuticals Shares Climb
www.nasdaq.com - April 8 at 4:40 PM
Navidea on go with mid-stage study of Tc99m tilmanocept in RA; shares up 13% premarketNavidea on go with mid-stage study of Tc99m tilmanocept in RA; shares up 13% premarket
seekingalpha.com - April 8 at 9:50 AM
Navidea Biopharmaceuticals Receives FDA Feedback Regarding Rheumatoid Arthritis Clinical Trial Design and Provides Business UpdatesNavidea Biopharmaceuticals Receives FDA Feedback Regarding Rheumatoid Arthritis Clinical Trial Design and Provides Business Updates
finance.yahoo.com - April 8 at 9:50 AM
Navidea Biopharmaceuticals Data to be Presented at Society of Nuclear Medicine and Molecular Imaging Annual MeetingNavidea Biopharmaceuticals Data to be Presented at Society of Nuclear Medicine and Molecular Imaging Annual Meeting
finance.yahoo.com - April 2 at 6:37 PM
Navidea Biopharmaceuticals Announces Stock Purchase Agreement; Other Business UpdatesNavidea Biopharmaceuticals Announces Stock Purchase Agreement; Other Business Updates
finance.yahoo.com - March 23 at 12:18 PM
Navidea Biopharmaceuticals (NAVB) CEO Jed Latkin on Q4 2018 Results - Earnings Call TranscriptNavidea Biopharmaceuticals (NAVB) CEO Jed Latkin on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 8 at 11:53 AM
Edited Transcript of NAVB earnings conference call or presentation 7-Mar-19 10:00pm GMTEdited Transcript of NAVB earnings conference call or presentation 7-Mar-19 10:00pm GMT
finance.yahoo.com - March 8 at 11:53 AM
Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial ResultsNavidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 7 at 4:19 PM
Navidea Biopharmaceuticals Schedules Fourth Quarter 2018 Earnings Conference Call and Business UpdateNavidea Biopharmaceuticals Schedules Fourth Quarter 2018 Earnings Conference Call and Business Update
finance.yahoo.com - February 28 at 11:46 AM
Navidea Biopharmaceuticals Announces Extension of NYSE American ListingNavidea Biopharmaceuticals Announces Extension of NYSE American Listing
finance.yahoo.com - February 1 at 11:10 AM
Navidea Biopharma to proceed with lawsuit against financierNavidea Biopharma to proceed with lawsuit against financier
seekingalpha.com - January 24 at 11:27 AM
Navidea Biopharmaceuticals Announces Decision by Ohio Supreme CourtNavidea Biopharmaceuticals Announces Decision by Ohio Supreme Court
finance.yahoo.com - January 24 at 11:27 AM
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel